CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Autifony Therapeutics Limited

For profitWebsite ↗

Also known as: Autifony Therapeutics Limited

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

May 12, 2023

Timeline

2010s

Jun 1, 2011
Autifony Therapeutics Limited— Founded

Drugs by trial phase (5 distinct, 8 trials)

Phase 2 (1 own, 0 via acquisition)

aut00063

Phase 1 (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (8)

NCT05873062Lead sponsorPhase 1May 12, 2023
NCT04158453Lead sponsorPhase 1Oct 10, 2019
NCT03164876Lead sponsorPhase 1Apr 20, 2017
NCT02935725Lead sponsorPhase 1Sep 1, 2016
NCT02832128Lead sponsorPhase 2May 1, 2016
NCT02589262Lead sponsorPhase 1Sep 1, 2015
NCT02345031Lead sponsorPhase 2Jan 1, 2015
NCT02315508Lead sponsorPhase 2Oct 1, 2014

Details

Founded: London, GB Jun 1, 2011
Last known activity: May 12, 2023